I bank with @firstrepublic ‘cos when I was without a full-time job in ‘13, they were the only one who looked at me as a person - analyzed my assets and income - and gave me a mortgage.
I have started 3 companies, all bank with them.
They do the work of a bank.
The work of a bank is to analyze the risk, make loans, keep the customer, and provide great service. The software is dated but the people are awesome.
I want my bank to pick up my phone. For 9 years, they have always picked up the phone - including this weekend.
Here some more for them @FDAOncology https://t.co/LlRYqdHfte “ctDNA Predicts Overall Survival in Patients With NSCLC Treated With PD-L1 Blockade or With Chemotherapy” $grts $ntra $imcr
$GRTS @gritstonebio let me do their homework @FDAOncology
Conclusion: The results suggest that ctDNA response might serve as a surrogate marker for OS. If validated, it may have great implications on the approval of new drugs. https://t.co/9XZvuzn0u7
"We already have the ability to generate vaccines that might provide more durable, variant-proof immunity, and this is to develop vaccines that contain conserved genes or gene regions that can act as targets for CD8+ T cells. https://t.co/theKTKLYTf
ctDNA clearance as an endpoint in #clinicaltrials..
📌We know that early changes/declines in ct🧬 is generally suggestive of tx benefit & a great place to test novel combinations.
However…
📌FDA guidance on ct🧬clearance: not a stand alone endpoint
#CRCTrialsChat#CRCSM